Stem cell standoff in Germany

Scientists and clinicians disagree over safety of using adult cells in cardiac patients

Written byJane Burgermeister
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

German scientists and clinicians are locked in a dispute over whether adult stem cells should be used to treat patients before the safety and effectiveness of the method has been fully proven.

The debate has hit the local media in recent days after scientists and clinicians presented new and apparently contradictory results on stem cells at the European Society of Cardiology congress in Vienna.

Cardiologist Bodo Eckehard Strauer from the University of Düsseldorf reported the results of a study of 34 heart attack patients who had been injected with adult stem cells drawn from their own bone marrow.

"Even patients with the most seriously damaged hearts can be treated with their own stem cells instead of waiting and hoping for a transplant," he said in Die Zeit newspaper.

Strauer said his study had shown that adult stem cell treatment could help those suffering from presently untreatable conditions and that more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery